Conjunctivitis Market
Conjunctivitis Market Size, Share & Trends Analysis Report
Conjunctivitis Market Size, By Type (Giant Papillary Conjunctivitis, Seasonal Allergic Conjunctivitis, Vernal Keratoconjunctivitis, Contact Conjunctivitis, Perennial Conjunctivitis, Atopic Keratoconjunctivitis), By Treatment (Mast Cell Stabilizers, Decongestant, Immunotherapy, Antihistamines, Non-steroidal Anti-Inflammatory Drugs, Olopatadine, Epinastine), Based On Region, And Segment Forecasts, 2024 – 2030
Published
Report ID : BMRC 3129
Number of pages : 300
Published Date : Dec 2024
Category : Healthcare
Delivery Timeline : 48 hrs
Key Players
- Atopix Therapeutics Ltd.
- Allegran
- Ocular Therapeutix, Inc.
- Santen Pharmaceutical Co. Ltd.
- Novartis
- Boehringer Ingelheim
- Pfizer Inc
- Allegran
- Sun Pharma
- Sirion Therapeutics, Inc.
Market Segmentations
By Type:
- Giant Papillary Conjunctivitis
- Seasonal Allergic Conjunctivitis
- Vernal Keratoconjunctivitis
- Contact Conjunctivitis
- Perennial Conjunctivitis
- Atopic Keratoconjunctivitis
By Treatment:
- Mast Cell Stabilizers
- Decongestant
- Immunotherapy
- Antihistamines
- Non-steroidal Anti-Inflammatory Drugs
- Olopatadine
- Epinastine
- Ointments
- Others
SUMMARY
Segments
Market Segmentations
By Type:
- Giant Papillary Conjunctivitis
- Seasonal Allergic Conjunctivitis
- Vernal Keratoconjunctivitis
- Contact Conjunctivitis
- Perennial Conjunctivitis
- Atopic Keratoconjunctivitis
By Treatment:
- Mast Cell Stabilizers
- Decongestant
- Immunotherapy
- Antihistamines
- Non-steroidal Anti-Inflammatory Drugs
- Olopatadine
- Epinastine
- Ointments
- Others
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players
- Atopix Therapeutics Ltd.
- Allegran
- Ocular Therapeutix, Inc.
- Santen Pharmaceutical Co. Ltd.
- Novartis
- Boehringer Ingelheim
- Pfizer Inc
- Allegran
- Sun Pharma
- Sirion Therapeutics, Inc.